UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:June 01,
Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Phio Pharmaceuticals Charts.
Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Phio Pharmaceuticals Charts.

Phio Pharmaceuticals Corp. News

Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
Tuesday 30 April 2024 (2 days ago) • GlobeNewswire Inc.
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
Tuesday 23 April 2024 (1 week ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Thursday 11 April 2024 (3 weeks ago) • GlobeNewswire Inc.
National Spotlight Features Phio’s Innovative RNAi Technology Platform
Wednesday 3 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 21 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

More Phio Pharmaceuticals Corp. News Articles